The pharmaceutical giant AstraZeneca PLC is reshaping its research and development operations with a growing presence in the Boston area. The goal is to ensure that more of the Anglo-Swedish company’s medicines make it to market, said Martin Mackay, who was recruited from a rival, Pfizer Inc., last summer to be AstraZeneca’s president of research and development.
